{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T05:15:05Z","timestamp":1775366105897,"version":"3.50.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"23","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.vaccine.2010.03.069","type":"journal-article","created":{"date-parts":[[2010,4,14]],"date-time":"2010-04-14T08:26:21Z","timestamp":1271233581000},"page":"3920-3928","source":"Crossref","is-referenced-by-count":25,"title":["Surveillance of invasive pneumococcal disease in 30 EU countries: Towards a European system?"],"prefix":"10.1016","volume":"28","author":[{"given":"Germaine","family":"Hanquet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Perrocheau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Kissling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel Levy","family":"Bruhl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Tarrag\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Stuart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pawel","family":"Stefanoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sigrid","family":"Heuberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Kriz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Vergison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine C.","family":"de Greeff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Amato-Gauci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia Pastore","family":"Celentano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.vaccine.2010.03.069_bib1","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1086\/341896","article-title":"Historical changes in pneumococcal serogroup distribution: implications for the era of pneumococcal conjugate vaccines","volume":"35","author":"Feikin","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2010.03.069_bib2","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/INF.0b013e318124a494","article-title":"Surveillance for invasive pneumococcal disease during 2000\u20132005 in a population of children who received 7-valent pneumococcal conjugate vaccine","volume":"26","author":"Black","year":"2007","journal-title":"Pediatr Infect Dis J"},{"issue":"January 1","key":"10.1016\/j.vaccine.2010.03.069_bib3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/01.inf.0000148891.32134.36","article-title":"Population-based surveillance for childhood invasive pneumococcal disease in the era of conjugate vaccine","volume":"24","author":"Hsu","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2010.03.069_bib4","unstructured":"Centers for Disease Control and Prevention (CDC). Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease, United States, 1998\u20132003.MMWR Morb Mortal Wkly Rep. 2005 September 16;54(36):893\u2013897."},{"issue":"9","key":"10.1016\/j.vaccine.2010.03.069_bib5","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1086\/521630","article-title":"Serotype replacement in invasive pneumococcal disease: where do we go from here?","volume":"196","author":"Hanage","year":"2007","journal-title":"J Infect Dis"},{"issue":"November 9","key":"10.1016\/j.vaccine.2010.03.069_bib6","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1086\/521626","article-title":"Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998\u20132004","volume":"196","author":"Hicks","year":"2007","journal-title":"J Infect Dis"},{"issue":"May 4","key":"10.1016\/j.vaccine.2010.03.069_bib7","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1017\/S0950268806007199","article-title":"Burden of paediatric invasive pneumococcal disease in Europe, 2005","volume":"135","author":"McIntosh","year":"2007","journal-title":"Epidemiol Infect"},{"issue":"7","key":"10.1016\/j.vaccine.2010.03.069_bib8","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S1473-3099(06)70520-5","article-title":"Streptococcus pneumoniae in Western Europe: serotype distribution and incidence in children less than 2 years old","volume":"6","author":"Jefferson","year":"2006","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2010.03.069_bib9","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S1473-3099(07)70061-0","article-title":"Streptococcus pneumoniae incidence in Western Europe","volume":"7","author":"Vergison","year":"2007","journal-title":"Lancet Infect Dis"},{"issue":"March 19","key":"10.1016\/j.vaccine.2010.03.069_bib10","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1016\/j.vaccine.2004.10.037","article-title":"Incidence of vaccine preventable pneumococcal invasive infections and blood culture practices in Italy","volume":"23","author":"D\u2019Ancona","year":"2005","journal-title":"Vaccine"},{"issue":"August 8","key":"10.1016\/j.vaccine.2010.03.069_bib11","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1017\/S0950268807009715","article-title":"Trends in incidence of pneumococcal disease before introduction of conjugate vaccine: South West England, 1996\u20132005","volume":"136","author":"Ihekweazu","year":"2008","journal-title":"Epidemiol Infect"},{"issue":"2","key":"10.1016\/j.vaccine.2010.03.069_bib12","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1086\/524660","article-title":"Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine","volume":"46","author":"Mu\u00f1oz-Almagro","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"35.","key":"10.1016\/j.vaccine.2010.03.069_bib13","article-title":"Impact of infant pneumococcal vaccination on invasive pneumococcal diseases in France, 2001\u20132006","volume":"13","author":"Lepoutre","year":"2008","journal-title":"Euro Surveill"},{"issue":"1","key":"10.1016\/j.vaccine.2010.03.069_bib14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1574-695X.2007.00283.x","article-title":"Invasive pneumococcal disease in Portugal prior to and after the introduction of pneumococcal heptavalent conjugate vaccine","volume":"51","author":"Dias","year":"2007","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2010.03.069_bib15","unstructured":"EUVAC.NET. Pneumococcal vaccination (PCV7) overview in European countries. http:\/\/www.euvac.net\/graphics\/euvac\/vaccination\/pcv7.html (accessed January 13)."},{"issue":"June 26","key":"10.1016\/j.vaccine.2010.03.069_bib16","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1016\/j.vaccine.2008.03.087","article-title":"Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway","volume":"26","author":"Vestrheim","year":"2008","journal-title":"Vaccine"},{"issue":"49","key":"10.1016\/j.vaccine.2010.03.069_bib17","article-title":"Use of 7-valent pneumococcal conjugate vaccine in EU","volume":"11","author":"Lopalco","year":"2006","journal-title":"Euro Surveill"},{"issue":"September 9","key":"10.1016\/j.vaccine.2010.03.069_bib18","first-page":"171","article-title":"European Union funded Pnc-EURO contributing group. Pneumococcal disease surveillance in Europe","volume":"11","author":"Pebody","year":"2006","journal-title":"Euro Surveill"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1000469X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1000469X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T08:38:37Z","timestamp":1559032717000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1000469X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":18,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0264410X1000469X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.03.069","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}